Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Accumulated Expenses (2018 - 2023)

Select Medical Holdings (SEM) has disclosed Accumulated Expenses for 6 consecutive years, with $157.7 million as the latest value for Q4 2023.

  • On a quarterly basis, Accumulated Expenses rose 428.7% to $157.7 million in Q4 2023 year-over-year; TTM through Dec 2023 was $157.7 million, a 428.7% increase, with the full-year FY2023 number at $157.7 million, up 428.7% from a year prior.
  • Accumulated Expenses was $157.7 million for Q4 2023 at Select Medical Holdings, up from $154.7 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $170.3 million in Q3 2019 to a low of $9.9 million in Q3 2021.
  • A 5-year average of $111.3 million and a median of $136.7 million in 2020 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: plummeted 92.08% in 2021, then skyrocketed 1393.46% in 2022.
  • Select Medical Holdings' Accumulated Expenses stood at $124.1 million in 2019, then rose by 7.01% to $132.8 million in 2020, then plummeted by 78.16% to $29.0 million in 2021, then grew by 2.88% to $29.8 million in 2022, then surged by 428.7% to $157.7 million in 2023.
  • Per Business Quant, the three most recent readings for SEM's Accumulated Expenses are $157.7 million (Q4 2023), $154.7 million (Q3 2023), and $159.2 million (Q2 2023).